Quick Takeaways
- TYBOURNE CAPITAL MANAGEMENT (HK) LTD filed SCHEDULE 13G/A for Forte Biosciences, Inc. Common Stock (FBRX).
- Disclosed ownership: 10%.
- Date of event: 30 Jun 2025.
Quoteable Key Fact
"TYBOURNE CAPITAL MANAGEMENT (HK) LTD disclosed 10% ownership in Forte Biosciences, Inc. Common Stock (FBRX) on 30 Jun 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 10% | 1,268,086 | 0 | 1,268,086 | /s/ Charlotte Fung | Charlotte Fung, Chief Financial Officer | |
| TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED | 10% | 1,268,086 | 0 | 1,268,086 | /s/ Viswanathan Krishnan | Viswanathan Krishnan, Director | |
| Tybourne Capital Management Ltd | 10% | 1,268,086 | 0 | 1,268,086 | /s/ Viswanathan Krishnan | Viswanathan Krishnan, Principal | |
| Tybourne Kesari Ltd | 10% | 1,268,086 | 0 | 1,268,086 | /s/ Viswanathan Krishnan | Viswanathan Krishnan, Principal | |
| Krishnan Viswanathan | 10% | 1,268,086 | 0 | 1,268,086 | /s/ Viswanathan Krishnan | Viswanathan Krishnan, Individually |